The Botox-maker snaps up a company that uses wireless technology to help control appetites. Who’s next?
|
Startup InnerPulse grabs the funding from venture capital and med-tech companies for implant to help folks survive sudden cardiac arrest.
|
Boston Scientific’s CFO stands ground that buying troubled heart device maker Boston Scientific was the best thing the company ever did.
|
Investors look to get insight on the medical device industry’s coming year with top chief Art Collins.
|
JPMorgan's annual healthcare confab. highlights trends and themes shaping the sector.
|
Private-equity buyout of orthopedics specialist could spur bids for rivals Zimmer, Smith & Nephew.
|
U.K. orthopedic maker Smith & Nephew confirms talks about possible competitor Biomet buyout.
|
Ablynx scores one of the year’s top European biotech deals.
|
Medical device maker squirrels away the money to deal with the legal woes of Guidant.
|
The heart device company hopes to raise funds to pump into drug-eluting stents.
|
Johnson & Johnson adds a company developing wound-closure technology to its pipeline.
|
As shares of orthopedics companies drop, Street struggles to make sense of investigations.
|
Conor Medsystems implants the first patient with a dual-drug heart device.
|
Abbott’s diagnostic lung cancer deal; cataract removal device study to start.
|
Zimmer gives women an implant designed with their unique physique in mind.
|
Boston Scientific gets U.S. government clearance to acquire troubled heart device maker Guidant.
|
Orthopedic maker Zimmer hopes to tap big market with its knee product for women.
|
An independent panel suggests how the troubled heart device maker can better its patient safety communication skills.
|
Israeli drug giant to help finance and commercialize technology based on technology for targeting apoptotic cells.
|
The call for less-invasive surgeries to treat orthopedic problems will drive industry’s innovation.
|
Page
1
of
3
|